News summary

LUNGevity Invests $1M+ in High-Priority Research to Expand Lung Cancer Workforce & Improve Patient Care

Source: PR Newswire • Published: 28 Oct 2026, 08:36

Summarized by Masters of Longevity from PR Newswire.

LUNGevity funded six awards to bolster the lung cancer research workforce.

LUNGevity Invests $1M+ in High-Priority Research to Expand Lung Cancer Workforce & Improve Patient Care
Key Takeaways
  • LUNGevity funded six awards to expand lung cancer investigators.
  • A drug reset cGAS-STING and improved immunotherapy in models.
  • A blood proteome study will seek predictors of immunotherapy response.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickCan Exergaming Improve Balance? What Older Adults Should KnowMotion-controlled games may make balance practice easier to repeat. The evidence supports a structured adjunct—not a fall-proofing shortcut.